Clinical Trial Update: Study of GS-3242 in Participants With HIV-1; Substudy-05 [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study of GS-3242 for HIV-1 infection that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GS-3242 (GS-3242)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 1 | Status: RECRUITING